JPMorgan Chase & Co. Buys 8,212,504 Shares of Healthpeak Properties, Inc. $DOC

JPMorgan Chase & Co. lifted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 41.0% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 28,236,534 shares of the real estate investment trust’s stock after purchasing an additional 8,212,504 shares during the quarter. JPMorgan Chase & Co. owned 4.06% of Healthpeak Properties worth $540,730,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Mather Group LLC. bought a new stake in Healthpeak Properties during the third quarter worth about $25,000. City Holding Co. bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $26,000. Rexford Capital Inc. bought a new stake in Healthpeak Properties during the 2nd quarter worth approximately $28,000. Sound Income Strategies LLC acquired a new stake in Healthpeak Properties during the 3rd quarter valued at $28,000. Finally, Elevation Point Wealth Partners LLC bought a new position in Healthpeak Properties in the 2nd quarter valued at $32,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently commented on DOC. Cantor Fitzgerald set a $17.00 target price on Healthpeak Properties in a report on Monday, January 5th. The Goldman Sachs Group began coverage on shares of Healthpeak Properties in a research report on Friday, January 9th. They set a “neutral” rating and a $17.00 target price on the stock. Robert W. Baird lowered their price target on shares of Healthpeak Properties from $21.00 to $20.00 and set an “outperform” rating for the company in a report on Wednesday, November 12th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a report on Tuesday, February 3rd. Finally, Argus cut Healthpeak Properties from a “buy” rating to a “hold” rating in a research note on Thursday, February 5th. Six equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Healthpeak Properties presently has an average rating of “Hold” and a consensus target price of $19.42.

Healthpeak Properties Stock Performance

Shares of NYSE:DOC opened at $17.12 on Thursday. Healthpeak Properties, Inc. has a fifty-two week low of $15.71 and a fifty-two week high of $21.28. The company has a debt-to-equity ratio of 1.21, a current ratio of 2.82 and a quick ratio of 2.82. The company has a market capitalization of $11.90 billion, a price-to-earnings ratio of 171.17, a P/E/G ratio of 9.24 and a beta of 1.12. The firm’s 50 day simple moving average is $16.81 and its 200 day simple moving average is $17.55.

Healthpeak Properties (NYSE:DOC) last announced its quarterly earnings results on Monday, February 2nd. The real estate investment trust reported $0.47 earnings per share for the quarter, topping analysts’ consensus estimates of $0.45 by $0.02. The company had revenue of $719.40 million for the quarter, compared to analysts’ expectations of $685.14 million. Healthpeak Properties had a net margin of 2.52% and a return on equity of 0.84%. The business’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same period last year, the firm posted $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.700-1.740 EPS. As a group, sell-side analysts forecast that Healthpeak Properties, Inc. will post 1.86 earnings per share for the current year.

Healthpeak Properties Dividend Announcement

The business also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a dividend of $0.1017 per share. This represents a c) annualized dividend and a yield of 7.1%. The ex-dividend date is Tuesday, March 17th. Healthpeak Properties’s dividend payout ratio (DPR) is 1,220.00%.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.